138 related articles for article (PubMed ID: 33014019)
1. Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data.
Liu J; Han M; Yue Z; Dong C; Wen P; Zhao G; Wu L; Xia J; Bin Y
Front Genet; 2020; 11():960. PubMed ID: 33014019
[TBL] [Abstract][Full Text] [Related]
2. Prediction of radiotherapy response with a 5-microRNA signature-based nomogram in head and neck squamous cell carcinoma.
Chen L; Wen Y; Zhang J; Sun W; Lui VWY; Wei Y; Chen F; Wen W
Cancer Med; 2018 Mar; 7(3):726-735. PubMed ID: 29473326
[TBL] [Abstract][Full Text] [Related]
3. Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset.
Dai D; Guo Y; Shui Y; Li J; Jiang B; Wei Q
Front Mol Biosci; 2021; 8():775562. PubMed ID: 34970597
[No Abstract] [Full Text] [Related]
4. Identification of 4-lncRNA prognostic signature in head and neck squamous cell carcinoma.
Diao P; Song Y; Ge H; Wu Y; Li J; Zhang W; Wang Y; Cheng J
J Cell Biochem; 2019 Jun; 120(6):10010-10020. PubMed ID: 30548328
[TBL] [Abstract][Full Text] [Related]
5. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
[TBL] [Abstract][Full Text] [Related]
6. Gene signature for prediction of radiosensitivity in human papillomavirus-negative head and neck squamous cell carcinoma.
Kim SI; Kang JW; Noh JK; Jung HR; Lee YC; Lee JW; Kong M; Eun YG
Radiat Oncol J; 2020 Jun; 38(2):99-108. PubMed ID: 33012153
[TBL] [Abstract][Full Text] [Related]
7. A seven-gene prognostic signature for rapid determination of head and neck squamous cell carcinoma survival.
Shen S; Bai J; Wei Y; Wang G; Li Q; Zhang R; Duan W; Yang S; Du M; Zhao Y; Christiani DC; Chen F
Oncol Rep; 2017 Dec; 38(6):3403-3411. PubMed ID: 29130107
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
[TBL] [Abstract][Full Text] [Related]
9. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
[TBL] [Abstract][Full Text] [Related]
10. Integrating Intrinsic Radiosensitivity and Immune Status for Predicting Benefits of Radiotherapy in Head and Neck Squamous Cell Carcinoma.
Sun C; Zhang M; Qiao Q; Wang Y
Med Sci Monit; 2021 Oct; 27():e932126. PubMed ID: 34670999
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Robust Immune Prognostic Signature for Head and Neck Squamous Cell Carcinoma.
Qiu Y; Cui L; Lin Y; Gao B; Li J; Zhao X; Zhu X; Hu S; Lin L
Front Oncol; 2020; 10():1502. PubMed ID: 33224866
[TBL] [Abstract][Full Text] [Related]
12. MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma.
Yuan Y; Ren J; Shi Y; Tao X
Eur J Radiol; 2019 Aug; 117():193-198. PubMed ID: 31307647
[TBL] [Abstract][Full Text] [Related]
13. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma.
Cao W; Liu JN; Liu Z; Wang X; Han ZG; Ji T; Chen WT; Zou X
Oral Oncol; 2017 Feb; 65():94-101. PubMed ID: 28109476
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures.
Serafini MS; Lopez-Perez L; Fico G; Licitra L; De Cecco L; Resteghini C
Cancers Head Neck; 2020; 5():2. PubMed ID: 31988797
[TBL] [Abstract][Full Text] [Related]
15. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
Wang P; Jin M; Sun CH; Yang L; Li YS; Wang X; Sun YN; Tian LL; Liu M
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355656
[TBL] [Abstract][Full Text] [Related]
16. Prediction of head and neck squamous cell carcinoma survival based on the expression of 15 lncRNAs.
Zhang B; Wang H; Guo Z; Zhang X
J Cell Physiol; 2019 Aug; 234(10):18781-18791. PubMed ID: 30927266
[TBL] [Abstract][Full Text] [Related]
17. Gene-expression signature predicts survival benefit from postoperative chemoradiotherapy in head and neck squamous cell carcinoma.
Chen J; Fu G; Chen Y; Zhu G; Wang Z
Oncol Lett; 2018 Aug; 16(2):2565-2578. PubMed ID: 30013651
[TBL] [Abstract][Full Text] [Related]
18. Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.
Xing L; Zhang X; Guo M; Zhang X; Liu F
DNA Cell Biol; 2020 Apr; 39(4):709-723. PubMed ID: 32045271
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a m
Zhao X; Cui L
Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
[TBL] [Abstract][Full Text] [Related]
20. A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients.
Wu S; Qiao Q; Li G
Front Oncol; 2020; 10():871. PubMed ID: 32612949
[No Abstract] [Full Text] [Related]
[Next] [New Search]